Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Aplidin ® (Plitidepsin) Activity In Peripheral T-Cell Lymphoma (PTCL): Final Results

Christophe Fermé, MD, Maria Victoria Mateos, MD, Sergio Szyldergemajn, MD, Claudia S. Corrado, MD, Emanuele Zucca, MD, Sonia Extremera, BSc, Alessandro M. Gianni, MD, Andrea Vandermeeren, BSc, Vincent Ribrag, MD

Blood (2010) 116 (21): 1767.

https://doi.org/10.1182/blood.V116.21.1767.1767

Published: 2010

Journal Articles

Aplidin Cardiac Safety Analysis.

Arturo Soto-Matos, MD, Sergio Szyldergemajn, MD, Javier Gomez, PhD, Sonia Extremera, BS, Bernardo Miguel-Lillo, PhD, Vicente Alfaro, PhD, Cinthya Coronado, MD, Pilar Lardelli, MD, Elena Roy, MD, Claudia S. Corrado, MD, Alejandro Yovine, MD, Carmen Kahatt, MD

Blood (2009) 114 (22): 4820.

https://doi.org/10.1182/blood.V114.22.4820.4820

Published: 2009

Journal Articles

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

Santiago Pavlovsky, MD, PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Virginia Prates, MD, Lucia Zoppegno, MD, Mario Giunta, MD, Ider Cerutti, MD, Elsa Palomino, MD, Fernando Pagani, MD, Francisco Lastiri, MD, Maria C. Narbaitz, MD, Fernando Cavagnaro, MD, Graciela Avila, MD

Blood (2006) 108 (11): 2474.

https://doi.org/10.1182/blood.V108.11.2474.2474

Published: 2006

Journal Articles

CD38 Expression Has an Important Value among Prognostic Factors in Chronic Lymphocytic Leukemia (CLL): A Multivariate Analysis in 160 Patients.

Carolina Pavlovsky, MD, Miguel A. Pavlovsky, MD, Maria L. Pardo, MD, Sandra Sapia, MD, Pablo Mountford, MD, Isolda I. Fernandez, MD, Claudia S. Corrado, MD, Mariana Juni Statistics, Santiago Pavlovsky, MD PhD

Blood (2004) 104 (11): 4779.

https://doi.org/10.1182/blood.V104.11.4779.4779

Published: 2004

Journal Articles

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Santiago Pavlovsky, MD PhD, Claudia S. Corrado, MD, Miguel A. Pavlovsky, MD, Mario Giunta, MD, Lucia Zoppegno, MD, Virginia Prates, MD, Francisco Lastiri, PhD, Ider Cerutti, MD, Maria C. Narbaitz, MD, Silvia Rudoy, MD, Fernando Cavagnaro, MD, Alejandra Kurchan, MD, Elsa Palomino, MD, Cesar Campo, MD

Blood (2004) 104 (11): 1310.

https://doi.org/10.1182/blood.V104.11.1310.1310

Published: 2004

NARROW

Aplidin ® (Plitidepsin) Activity In Peripheral T-Cell Lymphoma (PTCL): Final Results

Aplidin Cardiac Safety Analysis.

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

CD38 Expression Has an Important Value among Prognostic Factors in Chronic Lymphocytic Leukemia (CLL): A Multivariate Analysis in 160 Patients.

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Email alerts

ASH Publications

American Society of Hematology

Aplidin ® (Plitidepsin) Activity In Peripheral T-Cell Lymphoma (PTCL): Final Results

Aplidin Cardiac Safety Analysis.

Risk-Oriented Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT). Final Results of the Argentinian Group for Treatment of Acute Leukemia (GATLA) Phase III Study.

CD38 Expression Has an Important Value among Prognostic Factors in Chronic Lymphocytic Leukemia (CLL): A Multivariate Analysis in 160 Patients.

Risk-Adapted Therapy in Adults Previously Untreated Hodgkin’s Lymphoma (HL) with ABVD Followed by Involved Field Radiotherapy (IFRT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only